Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease-Reference-Cited by-同舟云学术

Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease

Published:2015-01 Issue:1 Volume:21 Page:159-164
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bhutani Divaya,Dyson Gregory,Manasa Richard,Deol Abhinav,Ratanatharathorn Voravit,Ayash Lois,Abidi Muneer,Lum Lawrence G.,Al-Kadhimi Zaid,Uberti Joseph P.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference23 articles.

1. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation;Bowden;N Engl J Med,1986

2. Risk factors for cytomegalovirus infection after human marrow transplantation;Meyers;J Infect Dis,1986

3. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening;Miller;Bone Marrow Transplant,1991

4. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation;Winston;Ann Intern Med,1987

5. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation;Meyers;N Engl J Med,1988

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Follow Up of Patients Treated for Inflammatory Bowel Disease and Cytomegalovirus Colitis;Diagnostics;2024-09-13

2. Acute diarrhea in the hospitalized immunocompromised patient: what is new on diagnostic and treatment?;Current Opinion in Critical Care;2024-07-19

3. Late cytomegalovirus disease after hematopoietic cell transplantation: significance of novel transplantation techniques;Blood Advances;2024-07-11

4. Viral enteritis after allogeneic hematopoietic stem cell transplantation: pathogens, clinical characteristics, and outcomes;2024-07-10

5. LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?;Mediterranean Journal of Hematology and Infectious Diseases;2024-04-30